The Journal of Microbiology and Antimicrobials (JMA) is an open access journal that provides rapid publication (monthly) of articles in all areas of the subject such as Disorders of the immune system, vaccines and antimicrobial drugs, Microbial Metabolism, Protozoology etc.

The Journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence. Papers will be published approximately one  month after acceptance. All articles published in JMA will be peer-reviewed.

Our objective is to inform authors of the decision on their manuscript within three weeks of submission. Following acceptance, a paper will normally be published in the next available issue.

Types of paper

Regular articles: These should describe new and carefully confirmed findings, and experimental procedures should be given in sufficient detail for others to verify the work. The length of a full paper should be the minimum required to describe and interpret the work clearly.

Short Communications: A Short Communication is suitable for recording the results of complete small investigations or giving details of new models or hypotheses, innovative methods, techniques or apparatus. The style of main sections need not conform to that of full-length papers. Short communications are 2 to 4 printed pages (about 6 to 12 manuscript pages) in length.

Reviews: Submissions of reviews and perspectives covering topics of current interest are welcome and encouraged. Reviews should be concise and no longer than 4-6 printed pages (about 12 to 18 manuscript pages). Reviews manuscripts are also peer-reviewed.  

See Instructions for Authors